Human Coactosin-like protein Recombinant Protein Product Attributes
Product Type: Recombinant Protein
Recombinant Coactosin-like protein based upon sequence from: Human
Host: QP7594 protein expressed in E. coli.
Tag: His-SUMO
Protein Construction: A DNA sequence encoding the Homo sapiens (Human) Coactosin-like protein, was expressed in the hosts and tags indicated. Please select your host/tag option, above.
Application Notes: Please contact us for application specific information for QP7594.
Bioactivity Data: Untested
Full Length? Full Length
Expression Region: Ala2 – Glu142
Amino Acid Sequence: ATKIDKEACR AAYNLVRDDG SAVIWVTFKY DGSTIVPGEQ GAEYQHFIQQ CTDDVRLFAF VRFTTGDAMS KRSKFALITW IGENVSGLQR AKTGTDKTLV KEVVQNFAKE FVISDRKELE EDFIKSELKK AGGANYDAQT E
Purity: Greater than 90% as determined by SDS-PAGE.
Reconstitution Instructions:
Concentration of Human Coactosin-like protein Protein:
Endotoxin Levels: Not determined.
Buffer: Tris-based buffer, 50% glycerol
Storage Conditions: Store at -20C to -80C.
Recombinant Human Coactosin-like protein Protein General Information | |
---|---|
Alternate Names | |
CLP | |
Curated Database and Bioinformatic Data | |
Gene Symbol | COTL1 |
Entrez Gene ID | 23406 |
Ensemble Gene ID | ENSG00000103187 |
RefSeq Protein Accession(s) | NP_066972.1 |
RefSeq mRNA Accession(s) | NM_021149.3 |
UniProt ID(s) | Q14019 |
UniGene ID(s) | Hs.289092 |
HGNC ID(s) | HGNC:18304 |
COSMIC ID Link(s) | COTL1 |
KEGG Gene ID(s) | hsa:23406 |
PharmGKB ID(s) | PA38522 |
General Description of Recombinant Human Coactosin-like protein Protein. | |
Binds to F-actin in a calcium-independent manner. Has no direct effect on actin depolymerization. Acts as a chaperone for ALOX5 (5LO), influencing both its stability and activity in leukotrienes synthesis. |
Limitations and Performance Guarantee
This is a life science research product (for Research Use Only). This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.
There are no reviews yet.